Does WINDTREE THERAPEUTICS INC (OTCMKTS:WINT) Have Gas After Even Less Sellers Involved?

June 15, 2018 - By Adrian Mccoy

The stock of WINDTREE THERAPEUTICS INC (OTCMKTS:WINT) registered a decrease of 10.71% in short interest. WINT’s total short interest was 2,500 shares in June as published by FINRA. Its down 10.71% from 2,800 shares, reported previously. With 6,700 shares average volume, it will take short sellers 0 days to cover their WINT’s short positions.

The stock decreased 11.17% or $0.44 during the last trading session, reaching $3.5. About shares traded. Windtree Therapeutics, Inc. (OTCMKTS:WINT) has 0.00% since June 15, 2017 and is . It has underperformed by 12.57% the S&P500.

Windtree Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing novel surfactant therapies for respiratory diseases and other potential applications. The company has market cap of $13.19 million. The Company’s proprietary technology platform includes a synthetic peptide-containing surfactant that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. It currently has negative earnings. The company??s lead development program comprises AEROSURF, a drug/device product that is in Phase IIb clinical trial to treat respiratory distress syndrome in premature infants.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: